GSK News and Activities
Presence
GSK is a global pharmaceuticals company focused on the research, development, and manufacturing of a wide range of prescription medicines, vaccines, and health-related consumer products. The company primarily serves healthcare facilities, governments, and general consumers seeking effective treatments for a variety of diseases and health conditions.
GSK products and services overview:
- Prescription Medicines
- Vaccines
- Consumer Healthcare Products
Employees: 99,000
GSK is one of the...
GSK is a company listed under the stock ticker GSK (GB).
GSK has a direct presence in 20 countries.GSK has 24 subsidiaries including Aiolos Bio, GSK ANZ and GSK APAC.
They are in:
Acquisition, funding and merger involving GSK.
- IDRx and GSK have merged (posted on February 24 2025)..
- GSK has announced the acquisition of IDRx (posted on January 13 2025).
- GSK has announced the acquisition of Aiolos Bio (posted on January 12 2024).
Executives
View the org chart displaying its 207 main executives
Most searched biographies at GSK
- Emma Walmsley, Chief Executive Officer and Director
- Jeannie Lee, Non-Executive Director
- Hal Barron, Non-Executive Director
Popular executive movements at GSK
- Vishwanath Swarup has joined the company as Commercial Head, General Medicines (posted on July 11 2025).
- Lauren Carey, who was Head of International, is promoted to Vice President and Global Vaccine Commercialisation (posted on July 7 2025).
- Sanjay Gurunathan has joined the company as Global Head, Vaccines and Infectious Disease, Research and Development (posted on June 12 2025).
Click here to view some more movements at GSK
Create your alert
to follow the executive moves at GSK.
Pharmaceuticals
GSK has 1,838 competitors including Pfizer (United States (USA)), Johnson & Johnson (United States (USA)) and Sanofi (France).
Popular M&A news in Pharmaceuticals
- ESSA Pharma and Xoma have announced they will merge (posted on July 14 2025)..
- Pathos becomes a unicorn with its fundraising of $365 Million. (posted on July 4 2025).
- Vor Biopharma and Incyte have announced they will merge (posted on June 30 2025)..
Popular contacts in Pharmaceuticals
News
Press releases by GSK
- GSK’s Nucala (mepolizumab) approved in China for treatment of adults with chronic rhinosinusitis with nasal polyps | GSK
- GSK announces FIRST trial met its primary endpoint of progression free survival in first line advanced ovarian cancer | GSK
- First single-dose medicine for P. vivax malaria prequalified by WHO and included in WHO Guidelines | GSK
- GSK and Zhifei revise and extend strategic vaccine collaboration in China | GSK
- Blenrep combinations accepted for review by the US FDA for the treatment of relapsed/refractory multiple myeloma | GSK
- Arexvy approval expanded to adults aged 50-59 at increased risk of severe RSV disease in Japan | GSK
- GSK’s fully liquid Menveo meningococcal vaccine approved by European Commission | GSK
- Linerixibat shows positive Phase III results in cholestatic pruritus (relentless itch) in primary biliary cholangitis (PBC) | GSK
- Statement: GSK continues to show strong leadership in its Access to Medicines Index ranking | GSK
- New GSK-sponsored survey reveals unique gaps in care and support facing patients with gynaecologic cancers | GSK
- View more press releases Close
Social media about GSK
- GSK on Wikipedia, Google News & Yahoo Finance
- GSK on LinkedIn, Twitter & YouTube
